Full-Time
Software Engineer
Frontend
Confirmed live in the last 24 hours
HeartFlow
501-1,000 employees
Non-invasive cardiac testing for heart disease
Compensation Overview
$91.9k - $166.6kAnnually
Mid, Senior
Austin, TX, USA
- Bachelor’s degree in Computer Science, or equivalent experience
- 3+ years of relevant industry experience at a software company, in software development
- 3+ years of hands-on experience with modern frontend technologies (e.g., Vue.js, JavaScript, React, Angular)
- Demonstrated experience in building and deploying large-scale, customer-facing web applications.
- Strong problem solving skills and ability to analyze complex issues.
- Proven track record of successful collaboration with product management and design teams.
- Experience with Agile development methodologies and project management tools.
- Strong understanding of web security best practices.
- Experience with DevOps best practices (e.g., CI/CD pipelines).
- Experience with or willingness to learn about FDA regulations and compliance requirements for medical software.
- Independent, end-to-end ownership of the design, development, testing, and maintenance of robust customer-facing interactive web applications and associated infrastructure.
- Work closely with API teams, Product, and UI/UX to ensure seamless integration and optimal functionality of web applications.
- Implement and maintain high standards for code quality, performance, and user experience.
- Ensure compliance with FDA regulations for medical software, including documentation, quality assurance processes, and adherence to regulatory standards in web application development.
- Contribute to a culture of innovation, best practices, and continuous improvement within the team.
HeartFlow provides a non-invasive cardiac test that helps visualize a patient's coronary arteries in detail. This technology allows physicians to diagnose and treat heart disease more effectively without the need for invasive procedures, which reduces risks for patients and costs for healthcare providers. HeartFlow's main clients are healthcare professionals seeking safer diagnostic methods. The company's product offerings include the HeartFlow Analysis, which encompasses various analyses like FFRCT, RoadMap, Plaque, and HeartFlow Planner, all of which have received FDA clearance and are available in the U.S., U.K., Japan, and Canada. HeartFlow differentiates itself from competitors by focusing on non-invasive solutions that enhance treatment planning. The company's goal is to improve cardiovascular care by providing tools that make diagnosis and treatment safer and more efficient.
Company Stage
Series F
Total Funding
$858.5M
Headquarters
Redwood City, California
Founded
2010
6 month growth
↑ 4%1 year growth
↑ 15%2 year growth
↑ 18%
Simplify's Take
What believers are saying
- Growing demand for AI-enabled diagnostic tools aligns with HeartFlow's solutions.
- The non-invasive cardiac imaging market is projected to grow at a 7.5% CAGR until 2028.
- Recent $215 million funding supports HeartFlow's commercial scale and product advancement.
What critics are saying
- Emerging AI-driven competitors could threaten HeartFlow's market share.
- Algorithmic bias in AI technology may affect diagnostic accuracy and patient outcomes.
- High costs may limit adoption in cost-sensitive healthcare markets, affecting revenue growth.
What makes HeartFlow unique
- HeartFlow offers the only combined anatomy, physiology, and plaque analysis for heart disease.
- Their AI-enabled technology provides non-invasive, personalized 3D heart models for precise diagnosis.
- HeartFlow's products are FDA-cleared and commercially available in major global markets.
Help us improve and share your feedback! Did you find this helpful?